Epidemiology of Uncontrolled Type 2 Diabetes Mellitus in Iranian Population.

Diabetes Mellitus affects large numbers of people in a wide range of ethnic groups and at all social and economic levels worldwide. This is exemplified by the dramatic increases in diabetes prevalence in newly developed and developing countries. As type 2 diabetes is so heterogeneous, for preventive measures to be fully effective in a community, they must be based on knowledge of the risk determinants in that community. Uncontrolled diabetes is currently a topic of considerable debate. Uncontrolled diabetes often leads to biochemical imbalances that can cause acute life-threatening events. Iran with a heterogeneous population of almost 70 million at the end of 2006 is located in the Middle East now has been confronted with this important issue. In 2005. Iranian CDC conducted a national health survey in the country. This study was conducted to describe the socio-demographic and clinical features and the level of glycemic control of subjects with diagnosed type 2 diabetes based on this national database. The survey was conducted on 89404 individuals in all provinces, (rural and urban) areas in Iran. Of total 2923 people were recognized as having type 2 diabetes. Age, gender, living area, obesity, educational level and family history for diabetes were determined and analyzed by employing logistic regression model. Fifty seven percent of people with type 2 diabetes (57%) (95%CI: 55.1-58.8%) had FPG>130 mg/dl indicating that their diabetes were uncontrolled. There was no statistically significant difference between male and female; literate an illiterate individuals. People with type 2 diabetes in rural areas had better control on their diabetes than people living in urban areas. In addition, we found that the control of FPG were much better in younger diabetic cases. Surprisingly, those diabetic cases that had positive family history had greater uncontrolled FPG(63% vs 52%). In conclusion the results of this study implies that health policy makers in Iranian health system should pay much more attention to tackle this health predicament particularly for elderly people and people with diabetes living in urban areas. [ABSTRACT FROM AUTHOR]